UNSPSC 51172828: Glycerin/phenol/sodium bicarbonate/sodium borate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OR500. This VA Drug Class (OR500) classifies this compound as belonging to the group MOUTHWASHES.

UNSPSC 51172828 Glycerin/phenol/sodium bicarbonate/sodium borate is a Commodity code under which state and local governments procure over-the-counter chemical and pharmaceutical products as inputs to healthcare and facility operations. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 seeking manufacturers of generic multi-source pharmaceuticals and OTC products—including the chemical compounds named in the code—for distribution across participating state and local government facilities in Minnesota and Oregon. Vendors must demonstrate cGMP certification, DSCSA compliance, and established relationships with AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, or Morris & Dickson Co., LLC as authorized wholesalers. The solicitation requires detailed product data submission (NDC codes, SKUs, UPCs, strength, dosage form, packaging configurations, and manufacturing location), pricing flexibility across multiple formats (flat price, net price, or WAC-minus structures), commercial general liability coverage of $5 million per occurrence, and network security and privacy liability of $2 million. Products must have expiration dates of at least one year from manufacture with a six-month minimum shelf life and be available in the marketplace by May 15, 2026.

The recent activity under this code is limited to the single MMCAP cooperative purchasing opportunity, which spans Minnesota and Oregon with awards effective July 1, 2026. The RFP evaluation weights price competitiveness at 75 percent, with administrative compliance (10 percent), EDI capability (5 percent), administrative fee agreement (5 percent), and pricing format compliance (5 percent) comprising the remainder. Proposals were due March 26, 2026, with a February 18, 2026 questions cutoff. MMCAP reserves multi-award authority based on therapeutic considerations and member-specific needs, with awarded vendors subject to a 3 percent administrative fee on all contract purchases and performance penalties ranging from $200 to $1,500 per violation for late reporting, missed onboarding timelines, or improper class-of-trade denials. The contract term is two years for new responders with optional extensions at MMCAP's discretion.